OC
英语轻松读发新版了，欢迎下载、更新

Iambic debuts next version of AI model Enchant, driving new way for drug R&D

2025-05-05 12:30:00 英文原文

作者：May 5, 2025 08:30 AM EDTUpdated 09:24 AM AI

Tom Miller, Iambic Therapeutics CEO

May 5, 2025 08:30 AM EDTUpdated 09:24 AM

Andrew Dunn

Senior Biopharma Correspondent

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

ENDPOINTS CAREERS

关于《Iambic debuts next version of AI model Enchant, driving new way for drug R&D》的评论

暂无评论

发表评论



摘要

Tom Miller, CEO of Iambic Therapeutics, is the focus of a recent article. The piece requires a subscription for full access and includes an opportunity to apply for a Uro-Oncology Business Manager position at ImmunityBio, Inc., which allows for remote work.

相关新闻

相关讨论